Trial begins for Endologix's aortic aneurysm device

03/5/2013 | American City Business Journals

Endologix is sponsoring a clinical study of its Ventana Fenestrated System, which features two branched stent grafts for maintaining blood flow in the kidneys and a main column to shield the aorta and prevent blood flow in the aneurysm. The FDA-approved trial will test whether the device is safe and effective in patients with pararenal and juxtarenal aortic aneurysms.

View Full Article in:

American City Business Journals

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Director, Compliance - Health Plan Privacy & Security
Kaiser Permanente
Oakland, CA
Regulatory Counsel
Food and Drug Administration
Silver Spring, MD
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Vice President, Commercial Markets
Meridian Health
Neptune, NJ